Green Prescription: weekly organic vegetable baskets and workshops for pregnant women
Official title: Evaluating Public Policy: A Case Study of the Green Prescription POLVERT (Green Policy - Evaluation and Results)
Run by University Hospital, Strasbourg, France · NCT07234617 · Data updated 2026-11-12
This project will test whether giving pregnant women weekly local organic vegetable baskets plus workshops lowers their pesticide exposure compared with their usual diet.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 210 (estimated) |
| Sponsor | University Hospital, Strasbourg, France Academic / other |
| Locations | 1 site (Strasbourg) |
| Status | Recruiting |
| Started | November 10, 2025 |
| Main results expected | August 2027 |
| Study ends | August 2027 |
| Registry record updated | November 19, 2025 |
| Trial ID | NCT07234617 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are pregnant women under 32 weeks of gestation who are over 18, fluent in French, registered with the Ordonnance Verte program, covered by social security, able to consent, and with telephone and internet access.
✕Probably not a fit
Women already consuming exclusively organic diets, those past 32 weeks of pregnancy, and those working in or living with someone in agriculture are unlikely to gain additional exposure reduction from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional public-health project enrolls pregnant women registered in the Green Prescription (Ordonnance Verte) program in Strasbourg and provides weekly baskets of local organic vegetables alongside awareness workshops about endocrine disruptors and healthy eating. Researchers will compare biomarkers of pesticide exposure in participants receiving the program to pregnant women who continue their usual eating habits. Eligible participants are adult pregnant women under 32 weeks, fluent in French and registered in the program; women working in or living with someone in agriculture are excluded. The design aims to measure whether the program reduces prenatal pesticide exposure and to generate evidence to inform broader policy rollout.
Why it matters
Potential benefit: If successful, the program could lower pregnant women's pesticide exposure and reduce risks to fetal development while providing evidence to support wider public-policy rollouts.
How similar studies have gone: Observational studies link prenatal pesticide exposure to harm, and a few small dietary intervention trials have reduced exposure, but large interventional public-policy evaluations like this are relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Be a woman * Be less than 32 weeks pregnant * Be registered with the "Ordonnance Verte" program * Have agreed, when registering for the program, to be contacted by a research team * Be affiliated with a social security system or be a beneficiary of such a system. * Be fluent in French. * Be over 18 years of age * Be able to understand the objectives and risks associated with the research and give dated and signed informed consent * Have a telephone and internet access Exclusion Criteria: * Participation in a study on nutrition or any other studies likely to affect exposure to the compounds under investigation * Inability to provide informed consent (difficulties in understanding on the part of the pregnant woman, etc.) * Being under judicial protection * Being under guardianship or conservatorship * Working in the agricultural sector (farmer, employee, apprentice) * Living with someone who works in the agricultural sector (farmer, employee, apprentice)
Where it's running
-
Hôpitaux Universitaires de Strasbourg
Strasbourg, France Recruiting
Study contacts
- Study coordinator: Virginie COLLIN-BUND, MD
- Email: virginie.bund@chru-strasbourg.fr
- Phone: +33 3 88 12 63 41
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pregnant Women Living with HIV on Bictegravir/Emtricitabine/Tenofovir Alafenamide
This study looks at how B/F/TAF is used in pregnant women with HIV and whether it helps maintain viral suppression from before conception through delivery.
-
Pelvic Floor Training and a Modified Lumbopelvic Belt for Symphysis Pubis Pain in Pregnancy
This study tests whether pelvic floor muscle training plus a modified lumbopelvic belt can reduce pain and improve function for pregnant women with symphysis pubis pain.
-
Effective Communication in VBAC Counseling
This study tests how clearly doctors and midwives explain VBAC options during prenatal visits and whether patients feel understood.
-
Innovative Multidisciplinary and Virtual Care for IBD in Pregnancy
This study tests a dedicated IBD pregnancy care model, including a new virtual approach, to see if it improves access and quality of care for pregnant people with Crohn's disease or ulcerative colitis.
-
Compare spinal-epidural versus general anesthesia for babies after cesarean delivery
This trial tests whether the type of anesthesia used for cesarean delivery affects newborn hearing in babies.
-
Pregnant women weight-management support via an app and care model
Aims to try a smartphone-based weight-management program plus professional support for pregnant women to see if it helps manage gestational weight and promote healthy behaviors.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.